Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06338748 · ClinicalTrials.gov registry record · NA
Accuracy of the Dexcom G7 Continuous Glucose Monitoring System Following Cardiac Surgery
A NA study, sponsored by The Cleveland Clinic.
- Completed
- Registry status
- NA
- Development phase
- 28
- Enrollment target
NCT06338748 is a NA study that has completed, run by The Cleveland Clinic. The registered enrollment target is 28 participants.
The verdict
NCT06338748, a NA study, has completed, sponsored by The Cleveland Clinic.
- COMPLETED
- Registry status
- NA
- Development phase
- 28 participants
- Enrollment target
Study Summary
This is a prospective longitudinal study to study the agreement between a continuous glucose monitoring system (CGMS) versus current blood glucose monitoring. Subjects in this study will have their blood glucose measured regularly every 1-3 hours with current methods in the Cardiovascular Intensive Care Unit (CVICU), and by Point of Care (POC) fingerstick glucose using the Accucheck Inform II on the regular floors, and the CGMS reading at the same time will be captured. Subjects will have measurements taken throughout their stay in the CVICU and on the regular floors. Agreement and correlation between systems, as well as errors, will be calculated.
Interventions
- DEVICE Continuous glucose monitor (CGM) Dexcom G7 used in blinded mode
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 28 participants |
| Start Date | 2024-11-02 |
| Est. Completion | 2025-12-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06338748
The ClinicalTrials.gov registry entry for NCT06338748 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 28 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is The Cleveland Clinic, which has 688 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Continuous glucose monitor (CGM) Dexcom G7 used in blinded mode is the first listed.
NCT06338748 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06338748 about?
NCT06338748 is a clinical study titled "Accuracy of the Dexcom G7 Continuous Glucose Monitoring System Following Cardiac Surgery". This is a prospective longitudinal study to study the agreement between a continuous glucose monitoring system (CGMS) versus current blood glucose monitoring. Subjects in this study will have their blood glucose measured regularly every 1-3 hours with current methods in the Cardiovascular Intensive ...
What is the current status of trial NCT06338748?
This trial is currently completed. It is a NA study. The enrollment target is 28 participants. The study started on 2024-11-02. Estimated completion is 2025-12-31.
What interventions are being tested in trial NCT06338748?
The interventions under investigation include: Continuous glucose monitor (CGM) Dexcom G7 used in blinded mode (DEVICE).
Who is sponsoring clinical trial NCT06338748?
This trial is sponsored by The Cleveland Clinic, which has 688 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.